logo
[breadcrumb_custom]

Tag: AIM ImmunoTech Inc. (AMEX:AIM)

Industry

AIM’s Stock Market Puzzle: Piecing Together 2023’s Performance

Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Until today this year the stock’s price performance recorded an increase of 26.85%. However, over the last six months, the performance has been weaker by 16.47%. The price of AIM increased 55.00% over the last 30 days. And in the last five days, it has surged by 17.18%. The market performance of AIM ImmunoTech Inc’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $0.75 on 07/21/23, while the

Finance

AIM ImmunoTech Inc (AIM) Stock: Navigating a Year of Stock Volatility

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. AIM ImmunoTech Inc’s current trading price is -37.09% away from its 52-week high, while its distance from the 52-week low is 47.14%. The stock’s price range over this period has fluctuated between $0.32 and $0.75. The company, operating within the financial sector, had a trading volume of approximately 0.42 million for the day, which was noticeably higher than the average daily share volume of 0.18 million over the last 3 months. AIM ImmunoTech Inc experienced a rather

News

AIM ImmunoTech Inc (AIM) Stock: Uncovering 52-Week Market Trends

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. AIM ImmunoTech Inc’s current trading price is -45.91% away from its 52-week high, while its distance from the 52-week low is 26.52%. The stock’s price range during this period has varied between $0.32 and $0.75. The company, active in the Healthcare sector, saw a trading volume of around 0.74 million for the day, considerably higher average daily volume of 0.15 million observed over the last three months. AIM ImmunoTech Inc’s stock has seen a rocky